$3.16
-0.08-2.47%
Pre-Market: 8:26 AM EDT
Comments
Loading...
Latest Fulcrum Therapeutics Stock News | NASDAQ:FULC | Benzinga
Get the latest news on Fulcrum Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Fulcrum Therapeutics performance
Categories: All
Wednesday, February 26, 2025
Tuesday, February 25, 2025
Monday, December 23, 2024
Thursday, November 14, 2024
Wednesday, November 13, 2024
Tuesday, November 12, 2024
Wednesday, October 02, 2024
Friday, September 27, 2024
Thursday, September 26, 2024
Tuesday, September 24, 2024
Friday, September 20, 2024
Friday, September 13, 2024
Thursday, September 12, 2024
- Leerink Partners Downgrades Fulcrum Therapeut...
- Dow Surges Over 100 Points; ModivCare Shares Plummet
- B of A Securities Downgrades Fulcrum Therapeu...
- Stifel Downgrades Fulcrum Therapeutics to Hol...
- Crude Oil Surges 3%; Kroger Posts Upbeat Earnings
- Fulcrum Therapeutics Suspends Rare Muscular Disease Candidate After Disappointing Data From Pivotal Trial
- Cantor Fitzgerald Downgrades Fulcrum Therapeu...
- US Stocks Mixed; Producer Prices Increase In August
- Market-Moving News for September 12th
- Fulcrum Therapeutics shares are trading lower...
- Fulcrum To Suspend Future Losmapimod Developm...
- Fulcrum Therapeutics' Phase 3 REACH Trial Of ...